Key result
Fibrin-associated diffuse large B-cell lymphoma can arise after endovascular aneurysm repair and mimic culture-negative aortic graft infection, requiring chemotherapy as the mainstay of treatment.
Why the study?
Fibrin-associated diffuse large B-cell lymphoma is a rare malignancy after vascular surgery that can mimic culture-negative aortic graft infection, presenting diagnostic and perioperative challenges.
Case Report (n=1)
Fibrin-associated diffuse large B-cell lymphoma is a rare complication after endovascular aneurysm repair that can mimic a mycotic aneurysm, requiring careful diagnosis and perioperative management.
Consider this lymphoma in culture-negative graft infections after vascular procedures; single case leaves open incidence and optimal diagnostics.
Fibrin-associated diffuse large B-cell lymphoma is a rare malignancy that can arise after vascular surgical procedures. Importantly, it can mimic culture-negative aortic graft infection with elevated inflammatory markers and avidity on positron emission tomography. Chemotherapy is the mainstay of treatment. This case highlights the challenges in the diagnosis and perioperative management of a patient with such a disease after complex endovascular aortic surgery.
No takes yet. Share an insight, caveat, or question.
Geiger et al. (2025) conducted a case report in Fibrin-associated diffuse large B-cell lymphoma (n=1). Endovascular aneurysm repair was evaluated. Fibrin-associated diffuse large B-cell lymphoma can arise after endovascular aneurysm repair and mimic culture-negative aortic graft infection, requiring chemotherapy as the mainstay of treatment.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: